المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
Click here for full text options
LibKey Link

المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
LibKey Link

المؤلفون: Mcdonald M., Forbes A., Marshall C., Grabsch E.

مصطلحات الفهرس: antiinfective agent/dt [Drug Therapy], antiinfective agent/pe [Pharmacoeconomics], beta lactam antibiotic/ct [Clinical Trial], beta lactam antibiotic/do [Drug Dose], beta lactam antibiotic/dt [Drug Therapy], beta lactam antibiotic/pe [Pharmacoeconomics], cefalotin/ct [Clinical Trial], cefalotin/do [Drug Dose], cefalotin/dt [Drug Therapy], cefalotin/pe [Pharmacoeconomics], cefazolin/ct [Clinical Trial], cefazolin/do [Drug Dose], cefazolin/dt [Drug Therapy], cefazolin/pe [Pharmacoeconomics], cefotaxime/ct [Clinical Trial], cefotaxime/do [Drug Dose], cefotaxime/dt [Drug Therapy], cefotaxime/pe [Pharmacoeconomics], cefoxitin/ct [Clinical Trial], cefoxitin/do [Drug Dose], cefoxitin/dt [Drug Therapy], cefoxitin/pe [Pharmacoeconomics], cefradine/ct [Clinical Trial], cefradine/do [Drug Dose], cefradine/dt [Drug Therapy], cefradine/pe [Pharmacoeconomics], ceftazidime/ct [Clinical Trial], ceftazidime/do [Drug Dose], ceftazidime/dt [Drug Therapy], ceftazidime/pe [Pharmacoeconomics], cefuroxime/ct [Clinical Trial], cefuroxime/do [Drug Dose], cefuroxime/dt [Drug Therapy], cefuroxime/pe [Pharmacoeconomics], cotrimoxazole/ct [Clinical Trial], cotrimoxazole/do [Drug Dose], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/pe [Pharmacoeconomics], doxycycline/ct [Clinical Trial], doxycycline/do [Drug Dose], doxycycline/dt [Drug Therapy], doxycycline/pe [Pharmacoeconomics], fleroxacin/ct [Clinical Trial], fleroxacin/do [Drug Dose], fleroxacin/dt [Drug Therapy], fleroxacin/pe [Pharmacoeconomics], gentamicin/ct [Clinical Trial], gentamicin/do [Drug Dose], gentamicin/dt [Drug Therapy], gentamicin/pe [Pharmacoeconomics], latamoxef/ct [Clinical Trial], latamoxef/do [Drug Dose], latamoxef/dt [Drug Therapy], latamoxef/pe [Pharmacoeconomics], metronidazole/ct [Clinical Trial], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], metronidazole/pe [Pharmacoeconomics], mezlocillin/ct [Clinical Trial], mezlocillin/do [Drug Dose], mezlocillin/dt [Drug Therapy], mezlocillin/pe [Pharmacoeconomics], piperacillin/ct [Clinical Trial], piperacillin/do [Drug Dose], piperacillin/pe [Pharmacoeconomics], tinidazole/ct [Clinical Trial], tinidazole/do [Drug Dose], tinidazole/dt [Drug Therapy], tinidazole/pe [Pharmacoeconomics], piperacillin/dt [Drug Therapy], antibiotic prophylaxis, clinical trial, dose response, drug efficacy, human, major surgery, postoperative infection/dm [Disease Management], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], practice guideline, review, surgical infection/dm [Disease Management], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], antiinfective agent/ct [Clinical Trial], antiinfective agent/do [Drug Dose], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33460
Australian and New Zealand Journal of Surgery
Click here for full text options
LibKey Link

المؤلفون: Mcdonald M., Forbes A., Marshall C., Grabsch E.

مصطلحات الفهرس: antiinfective agent/dt [Drug Therapy], antiinfective agent/pe [Pharmacoeconomics], beta lactam antibiotic/ct [Clinical Trial], beta lactam antibiotic/do [Drug Dose], beta lactam antibiotic/dt [Drug Therapy], beta lactam antibiotic/pe [Pharmacoeconomics], cefalotin/ct [Clinical Trial], cefalotin/do [Drug Dose], cefalotin/dt [Drug Therapy], cefalotin/pe [Pharmacoeconomics], cefazolin/ct [Clinical Trial], cefazolin/do [Drug Dose], cefazolin/dt [Drug Therapy], cefazolin/pe [Pharmacoeconomics], cefotaxime/ct [Clinical Trial], cefotaxime/do [Drug Dose], cefotaxime/dt [Drug Therapy], cefotaxime/pe [Pharmacoeconomics], cefoxitin/ct [Clinical Trial], cefoxitin/do [Drug Dose], cefoxitin/dt [Drug Therapy], cefoxitin/pe [Pharmacoeconomics], cefradine/ct [Clinical Trial], cefradine/do [Drug Dose], cefradine/dt [Drug Therapy], cefradine/pe [Pharmacoeconomics], ceftazidime/ct [Clinical Trial], ceftazidime/do [Drug Dose], ceftazidime/dt [Drug Therapy], ceftazidime/pe [Pharmacoeconomics], cefuroxime/ct [Clinical Trial], cefuroxime/do [Drug Dose], cefuroxime/dt [Drug Therapy], cefuroxime/pe [Pharmacoeconomics], cotrimoxazole/ct [Clinical Trial], cotrimoxazole/do [Drug Dose], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/pe [Pharmacoeconomics], doxycycline/ct [Clinical Trial], doxycycline/do [Drug Dose], doxycycline/dt [Drug Therapy], doxycycline/pe [Pharmacoeconomics], fleroxacin/ct [Clinical Trial], fleroxacin/do [Drug Dose], fleroxacin/dt [Drug Therapy], fleroxacin/pe [Pharmacoeconomics], gentamicin/ct [Clinical Trial], gentamicin/do [Drug Dose], gentamicin/dt [Drug Therapy], gentamicin/pe [Pharmacoeconomics], latamoxef/ct [Clinical Trial], latamoxef/do [Drug Dose], latamoxef/dt [Drug Therapy], latamoxef/pe [Pharmacoeconomics], metronidazole/ct [Clinical Trial], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], metronidazole/pe [Pharmacoeconomics], mezlocillin/ct [Clinical Trial], mezlocillin/do [Drug Dose], mezlocillin/dt [Drug Therapy], mezlocillin/pe [Pharmacoeconomics], piperacillin/ct [Clinical Trial], piperacillin/do [Drug Dose], piperacillin/pe [Pharmacoeconomics], tinidazole/ct [Clinical Trial], tinidazole/do [Drug Dose], tinidazole/dt [Drug Therapy], tinidazole/pe [Pharmacoeconomics], piperacillin/dt [Drug Therapy], antibiotic prophylaxis, clinical trial, dose response, drug efficacy, human, major surgery, postoperative infection/dm [Disease Management], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], practice guideline, review, surgical infection/dm [Disease Management], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], antiinfective agent/ct [Clinical Trial], antiinfective agent/do [Drug Dose], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33460
Australian and New Zealand Journal of Surgery
Click here for full text options
LibKey Link